In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharming Group N.V.

http://www.pharming.com

Latest From Pharming Group N.V.

Finance Watch: VC Mega-Rounds Are Alive And Well

Private Company Edition: Also, Catalio closed a $381m venture capital fund and OrbiMed’s SEC filings indicate it is in the process of raising $4.75bn across three new funds. Dianthus launched with $100m and Tubulis closed a $63m series B round.

Financing Innovation

More Imports Of Counterfeit OTC COVID-19 Tests Reaching US

Counterfeit versions of diagnostics from ACON Laboratories and iHealth are being illegally imported and sold in US. Alert also tells consumers how to spot counterfeit tests.

Coronavirus COVID-19 FDA

FDA Warns About Counterfeit COVID-19 Tests

Counterfeit versions of diagnostics from ACON Laboratories and iHealth are being illegally imported to and sold in the US, the agency says. The alert also tells consumers how to spot counterfeit tests.

Regulation Coronavirus COVID-19

Tech Transfer Roundup: Lysogene Elects Option On Gene Therapy Discovered At Weizmann Institute

French biotech brings candidate for Gaucher and Parkinson’s disease in-house under 2020 pact with Weizmann. Cellevolve, Seattle Children’s partner on cell therapies for CNS cancers.

Tech Transfer Round-Up Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
    • Synthesis Technologies, Production Processes
    • Transgenics
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register